对癌症和阿片类药物使用障碍患者的同情关怀
Katie Fitzgerald Jones1, Kathleen Broglio, J Janet Ho
1Katie Fitzgerald Jones is a palliative and addiction NP and researcher in the VA Boston Healthcare System. Kathleen Broglio is associate professor of medicine in the Geisel School of Medicine at Dartmouth, Hanover, NH. J. Janet Ho is a palliative and addiction medicine physician at the University of California, San Francisco. William E. Rosa is assistant attending behavioral scientist, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York City. Contact author: Katie Fitzgerald Jones, jonesafq@bc.edu. The authors have disclosed no potential conflicts of interest, financial or otherwise.
在癌症患者中管理阿片类药物使用障碍 (OUD) 需要综合策略. 本文概述了安全的阿片类药物管理方法,包括动机面试和减少癌症疼痛的危害.
科学领域:
- 在瘤学瘤学.
- 成 药物 药物 药物 药物
- 抚慰性护理是一种缓解性护理.
背景情况:
- 阿片类药物使用障碍 (OUD) 在癌症护理中构成了重大挑战.
- 对于患有癌症相关疼痛的患者来说,有效的OUD管理至关重要.
研究的目的:
- 讨论OUD癌症患者安全阿片类药物管理的策略.
- 突出核心疼痛管理方法和以人为中心的终身护理.
主要方法:
- 使用一个复合案例示例来说明管理策略.
- 审查了包括激励面试,减少伤害和基于证据的治疗方法在内的方法.
主要成果:
- 安全的阿片类药物管理可以在患有OUD的癌症患者中实现.
- 综合策略可以有效地解决疼痛和OUD.
结论:
- 在癌症患者的OUD管理中,必须采用多学科的方法.
- 应优先考虑以人为中心的护理,包括生命终端护理.
更多相关视频
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
相关概念视频
Continuing Care
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Treatment Resistant Cancers
Patient-centered Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chronic Pancreatitis II: Collaborative Care
Assessment:
